Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...

A new medical large language model (LLM) achieved over 91% accuracy in identifying female participants diagnosed with major ...

In the previous post, readers were reacquainted with the basics of major depressive disorder (MDD). Today, we will start looking at the subtypes, beginning with major depression with psychotic ...

Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...

A new medical large language model (LLM) achieved over 91 percent accuracy in identifying female participants diagnosed with ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

The American College of Lifestyle Medicine, or ACLM, released a new expert consensus statement on the role of lifestyle ...